Bonney Michael W insider trades
Bonney Michael W has filed 13 Form 4s with the SEC that we hold, for Alnylam Pharmaceuticals, INC. (ALNY) (Director), Autolus Therapeutics plc (AUTL) (Director), Bristol Myers Squibb Co (BMY) (Director) and Immunic, INC. (IMUX) (Director), among 5 companies in all. Across all of them we count 0 purchases worth $0 and 23 sales worth $15.2M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 30,000 shares of Alnylam Pharmaceuticals, INC. worth $5.8M, dated 2023-12-27. The first filing on our record is dated 2021-07-01 and the latest 2026-07-01.
Alnylam Pharmaceuticals, INC. (ALNY)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-08-03 | S, sale reported on Form 4 | 1,714 | $318.8K | 2023-08-04 |
| 2023-08-03 | S, sale reported on Form 4 | 450 | $84.5K | 2023-08-04 |
| 2023-08-03 | S, sale reported on Form 4 | 560 | $102.9K | 2023-08-04 |
| 2023-08-03 | S, sale reported on Form 4 | 500 | $91.2K | 2023-08-04 |
| 2023-08-03 | S, sale reported on Form 4 | 300 | $54.3K | 2023-08-04 |
| 2023-08-03 | S, sale reported on Form 4 | 1,535 | $283.8K | 2023-08-04 |
| 2023-08-03 | S, sale reported on Form 4 | 1,389 | $259.8K | 2023-08-04 |
| 2023-12-27 | S, sale reported on Form 4 | 30,000 | $5.8M | 2023-12-29 |
| 2025-05-15 | S, sale reported on Form 4 | 882 | $241.4K | 2025-05-19 |
| 2025-05-15 | S, sale reported on Form 4 | 301 | $83.0K | 2025-05-19 |
| 2025-05-15 | S, sale reported on Form 4 | 1,263 | $350.1K | 2025-05-19 |
| 2025-05-15 | S, sale reported on Form 4 | 1,239 | $344.5K | 2025-05-19 |
| 2025-05-15 | S, sale reported on Form 4 | 432 | $121.0K | 2025-05-19 |
| 2025-05-15 | S, sale reported on Form 4 | 372 | $104.6K | 2025-05-19 |
| 2025-05-15 | S, sale reported on Form 4 | 802 | $226.2K | 2025-05-19 |
| 2025-05-15 | S, sale reported on Form 4 | 1,728 | $488.7K | 2025-05-19 |
| 2025-05-15 | S, sale reported on Form 4 | 1,617 | $459.0K | 2025-05-19 |
| 2025-05-15 | S, sale reported on Form 4 | 660 | $180.3K | 2025-05-19 |
| 2025-05-15 | S, sale reported on Form 4 | 431 | $117.1K | 2025-05-19 |
| 2025-05-15 | S, sale reported on Form 4 | 729 | $195.8K | 2025-05-19 |
| 2025-05-15 | S, sale reported on Form 4 | 245 | $66.1K | 2025-05-19 |
| 2025-05-15 | S, sale reported on Form 4 | 549 | $146.7K | 2025-05-19 |
| 2025-08-18 | S, sale reported on Form 4 | 11,250 | $5.1M | 2025-08-19 |
Autolus Therapeutics plc (AUTL)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Bristol Myers Squibb Co (BMY)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Immunic, INC. (IMUX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
KLDO
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1219016) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms